Supplemental vitamin D and physical performance in COPD: A pilot randomized trial

International Journal of COPD

Volumn 8, Issue , 2013, Pages 97-104

  Bjerk, Sonja M ^a   Edgington, Bradley D ^a   Rector, Thomas S ^a,b   Kunisaki, Ken M ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Randomized controlled trial; Skeletal muscle strength; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; PLACEBO;

AGED; ARTICLE; BODY EQUILIBRIUM; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHYSICAL PERFORMANCE; PILOT STUDY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SHORT PHYSICAL PERFORMANCE BATTERY SCORE; STANDING; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WALKING SPEED;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE STRENGTH; VITAMIN D;

AGED; CHOLECALCIFEROL; EXERCISE TEST; GAIT; HUMANS; LINEAR MODELS; MALE; MUSCLE STRENGTH; PILOT PROJECTS; POSTURAL BALANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMINS;

EID: 84873957886     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S40885     Document Type: Article

References (36)

1. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10:417-423.
2. Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lowerextremity function in both active and inactive persons aged ≥60 y. Am J Clin Nutr. 2004;80:752-758.
3. Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058-2065.
4. Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002;13:187-194.
5. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19:265-269.
6. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291:1999-2006.
7. Moyer VA; on behalf of the US Preventive Services Task Force. Prevention of falls in community-dwelling older adults: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012;157:197-204.
8. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 2005;20:187-192.
9. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010;65:215-220.
10. Kunisaki KM, Niewoehner DE, Connett JE; COPD Clinical Research Network. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med. 2012;185:286-290.
11. Institute of Medicine, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. 1997. Available from: http://www.ncbi.nlm.nih.gov/books/NBK109825/. Accessed January 15, 2013.
12. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-M94.
13. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55:M221-M231.
14. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54:743-749.
15. Corsonello A, Lattanzio F, Pedone C, et al; on behalf of The Pharmacosurveillance In The Elderly Care Pvc Study Investigators RA. Prognostic significance of the Short Physical Performance Battery in older patients discharged from acute care hospitals. Rejuvenation Res. 2012;15:41-48.
16. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556-561.
17. Volpato S, Cavalieri M, Guerra G, et al. Performance-based functional assessment in older hospitalized patients: feasibility and clinical correlates. J Gerontol A Biol Sci Med Sci. 2008;63:1393-1398.
18. Volpato S, Cavalieri M, Sioulis F, et al. Predictive value of the Short Physical Performance Battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci. 2011;66:89-96.
19. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008;121: 789-796.
20. Singer J, Yelin EH, Katz PP, et al. Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev. 2011;31:111-119.
21. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991;85 Suppl B:25-31.
22. Jones PW. St George's Respiratory Questionnaire: MCID. COPD. 2005;2:75-79.
23. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
24. Berry MJ, Rejeski WJ, Miller ME, et al. A lifestyle activity intervention in patients with chronic obstructive pulmonary disease. Respir Med. 2010;104:829-839.
25. Geusens P, Vandevyver C, Vanhoof J, Cassiman JJ, Boonen S, Raus J. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J Bone Miner Res. 1997;12:2082-2088.
26. Costa EM, Blau HM, Feldman D. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology. 1986;119:2214-2220.
27. De Boland AR, Boland RL. Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal. 1994;6:717-724.
28. Norman AW, Nemere I, Zhou LX, et al. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol. 1992;41:231-240.
29. Hopkinson NS, Li KW, Kehoe A, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008;87:385-390.
30. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18:343-351.
31. Wang Y, DeLuca H. Is the vitamin D receptor found in muscle? Endocrinology. 2011;152:354.
32. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234-239.
33. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000;15:1113-1118.
34. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303:1815-1822.
35. Hornikx M, Van Remoortel H, Lehouck A, et al. Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res. 2012;13:84.
36. Jackson AS, Shrikrishna D, Kelly JL, et al. Vitamin D and skeletal muscle strength and endurance in chronic obstructive pulmonary disease. Eur Respir J. 2013;41:309-316.